Preliminary PROGRAM - AFITCH-OR

2016
27th International Congress on Anti-Cancer Treatment
Centre de Conférence
étoile saint-honoré
Preliminary
PROGRAM
2-4 February
2016
21-23-25 rue Balzac - 75008 Paris
Presidents
David Khayat, MD, PhD - Paris, France
Gabriel N. Hortobagyi, MD, Phd - Houston, USA
General Secretaries
Peter Harper, MD - London, UK
Moïse Namer, MD, Phd - Nice, France
Endorsed by
This program has the American Society of
Clinical Oncology’s approval for quality of
educational content. ASCO endorsement
does not constitute medical advice. Health
care providers should exercise their own
independent medical judgment. ASCO®
is a registered trademark of the
American Society of Clinical
Oncology®. Used with
permission. This is not
an ASCO sponsored event.
©réa : Hervé Mich@ud-MDA - 2016
www.icact.com
27th International Scientific Committee
• ANDRÉ Fabrice
• ANDRÉ Thierry
• ANDRY Guy • BASTIAN Gérard • BAULIEUX Jacques • BENJAMIN Robert S. • BIZZARI Jean-Pierre • BLAY Jean-Yves • BONVALOT Sylvie
• BOYLE Peter • BRASNU Daniel • BUTHIAU Didier • CASSOUX Nathalie • CHAHINE Georges
• CHIRAS Jacques • CLASSE Jean-Marc • COHEN-ALORO Gilbert • COINDRE Jean-Michel
• CONTE Pier-Franco • CORTES Javier
• COSSET Jean-Marc • CUSSENOT Olivier • DALIVOUST Philippe • DEBUS Juergen
• DE GRAMONT Aimery • DELALOGE Suzette • DIAZ-RUBIO Eduardo • DOUILLARD Jean-Yves • DUCREUX Michel • EGGERMONT Alexander
• EVENO Clarisse
• FIZAZI Karim • FRYDMAN René • FUMOLEAU Pierre • GEORGOULIAS Vassilis • GIANNI Luca • GIL-DELGADO Marian • GISSELBRECHT Christian • GLEHEN Olivier
• GLIGOROV Joseph • GOÉRÉ Diane • GOODWIN Pamela • GORNET Jean-Marc • GOUIN François • GRUNENWALD Dominique • GUARNERI Valentina • HANNOUN Laurent • HARPER Peter • HATAKE Kiyohiko • HERRERA Alain • HORTOBAGYI Gabriel • HUDIS Clifford
• JUDET Henri • KAYITALIRE Louis • KHAYAT David • KNOPF Alain • LAUNOIS Bernard • LE CESNE Axel • LECOINTE Estelle
• LEFEBVRE Jean-Louis • LEJEUNE Ferdy • LICHINITSER Michael • LINK Karl Heinrich • LO DICO Réa • Loriot Yohann
• LUCIDARME Olivier • Malouf Gabriel
• MANTION Georges • MARRE Philippe • MARTIN Miguel • MAZERON JJacques • MEEUS Pierre • MENEGAUX Fabrice • MEUNIER Bernard • MILANO Gérard • MISSENARD Gilles • MORERE J.François • MORNEX Françoise • Mottet Nicolas
• MULARONI Elena • MULVEY Thérèse • NAMER Moïse • PENAULT-LLORCA Frédérique
• PEREZ Edith • PICCART Martine • PIVOT Xavier • POMEL Christophe • PRITCHARD Kathleen I. • RAY-COQUARD Isabelle
• ROSELL Rafael • ROUGIER Philippe • ROUZIER Roman
• SAIJO Nagahiro • SALMON Rémy • SCAGLIOTTI Georgio • SHEPHERD Frances • SCHNEIDER Maurice • SOBRERO Alberto • SORIA Jean-Charles
• SOTIRIOU Christos • SPANO Jean-Philippe • SPIELMANN Marc
• Sun Ying-Hao • SWAIN Sandra • TABERNERO Josep • TAILLADE Laurent • TOLEDANO Alain • TOUBOUL Cyril • TSUJI Yasushi • UZAN Serge • VAN CUTSEM Eric • VAN GESTEL Dirk
• VAN POPPEL Henrik • VERMORKEN Jan B. • VILLENEUVE Laurent
Villejuif, France
Paris, France
Brussels, Belgium
Paris, France
Lyon, France
Houston, USA
New York, USA
Lyon, France
Paris, France
Lyon, France
Paris, France
Paris, France
Paris, France
Beirut, Lebanon
Paris, France
Nantes, France
Orange, France
Bordeaux, France
Padova, Italy
Barcelona, Spain
Paris, France
Paris, France
Marseille, France
Heidelberg, Germany
Paris, France
Paris, France
Madrid, Spain
Nantes St Herblain, France
Villejuif, France
Villejuif, France
Paris, France
Villejuif, France
Clamart, France
Dijon, France
Crete, Greece
Milano, Italy
Paris, France
Paris, France
Lyon, France
Paris, France
Villejuif, France
Toronto, Canada
Paris, France
Nantes, France
Paris, France
Padova, Italy
Paris, France
London, UK
Tokyo, Japan
Paris, France
Houston, USA
New-York, USA
Paris, France
New Jersey, USA
Paris, France
Asnières, France
Paris, France
Villejuif, France
Rennes, France
Lille, France
Lausanne, Switzerland
2
Moscow, Russia
Wiesbaden, Germany
Paris, France
Villejuif, France
Paris, France
Paris, France
Paris, France
Paris, France
Madrid, Spain
Paris, France
Lyon, France
Paris, France
Rennes, France
Nice, France
Paris, France
Bobigny, France
Lyon, France
Saint-Etienne, France*
Cailungo, San Marino
Boston, USA
Nice, France
Clermont-Ferrand, France
Jacksonville, USA
Brussels, Belgium
Besançon, France
Clermont-Ferrand, France
Toronto, Canada
Lyon, France
Baladona, Spain
Paris, France
Paris, France
Osaka, Japan
Paris, France
Turino, Italy
Toronto, Canada
Nice, France
Genoa, Italy
Villejuif, France
Brussels, Belgium
Paris, France
Villejuif, France
Shanghai, Chine
Washington, USA
Barcelona, Spain
Paris, France
Neuilly/Seine, France
Créteil, France
Sapporo, Japan
Paris, France
Leuven, Belgium
Brussels, Belgium
Leuven, Belgium
Edegem, Belgium
Founding President :
• Pr Claude Jacquillat † Paris, France
Honorary Presidents :
• Pr Pierre Banzet • Pr James Holland Paris, France
New York, USA
Scientific Symposium
on Preliminary Program
Scientific Symposia are sessions during which some of the world best experts will, upon invitation,
address different issues related to a specific topic. Each scientific symposium will end
with a round table discussion
6 Tuesday 2nd February
n
n
ORION
Head & Neck Cancers
9:00-12:30
Chaired by Jan B. Vermorken
Breast Cancer (1)
Quality of Care
Chaired by S. M. Swain & P.F Conté
• Guy ANDRY – Brussels, Belgium
Quality Assurance in Surgery: wishful thinking?
• Sandra M. SWAIN – Washington, USA
HER2 positive breast cancer: Updates in Metastatic
disease
• Pier-Franco CONTE – Padua, Italy
Treatment duration of HER2+ early breast cancer:
still a matter of debate?
• Valentina GUARNERI – Padua, Italy Therapeutic algorithm of HER2+ advanced breast
cancer
• Clifford HUDIS – Houston, USA
The role of increasing obesity in cancer
• Dirk VAN GESTEL – Brussels, Belgium
Quality Assurance (QA) in Radiotherapy: how important
is it?
• Juergen DEBUS – Heidelberg, Germany
Proton and Ion Beam Radiotherapy: will its promise
come true?
• Jan B. VERMORKEN – Edegem, Belgium
Does it make a difference how you deliver the drugs?
12:30-14:00 Adjourn
n
VEGA
14:00-17:30
n
ORION
BOREAL
9:00-12:30
Lung Cancer
14:00-17:30
Breast Cancer (2)
Chaired by F. Shepherd & G. Tazzioli
Chaired by C. Hudis & M. Piccart
• Marc BOLLET – Levallois, France
Cyberknife and lung cancer
• Martine PICCART – Brussels, Belgium
Clinical trials in the “omics” era: a learning experience
• Françoise MORNEX – Lyon, France*
Stage III NSCLC: State of the art
• Gabriel N. HORTOBAGYI – Houston, USA
• Rafael ROSELL – Baladona, Spain*
Combinatorial targeted therapy in EGFR mutant lung
cancer – A burning need to improve survival
Prognostic and Predictive Tools in Breast Cancer:
Clinical and Genomic
• Edith PEREZ – Jacksonville, USA
Immune modulatory approaches for breast cancer
• Frances SHEPHERD – Toronto, Canada
Managing T790M mutation positive adenocarcinoma of
the lung
• Clifford HUDIS – Houston, USA
The use of big data in cancer: ASCO’s CancerLinQ
12:30-14:00 Adjourn
*Not yet confirmed
3
Scientific Symposium on Preliminary Program
6 Tuesday 2nd February
n
n
VEGA
BOREAL
14:00-17:30
Les Cordeliers
Prostate Cancer
15, rue de l’École de Médecine - 75006 Paris- tél :01 43 54 02 32
[email protected] www.academie-chirurgie.fr
www.facebook.com/academie.chirurgie / Agréée formation N°11 75 23485 75
Chaired by H. Van Poppel & G. Malouf
Presidency : Henri JUDET(French Academy of Surgery),
David KHAYAT (ICACT/Fondation AVEC)
Scientific Coordinator : Philippe MARRE
• Yohann Loriot, Villejuif, France*
Prostate cancer heterogeneity and aggressive variants
• Gabriel Malouf, Paris, France
Development of gene signatures in prostate cancer
6 Wednesday February 3rd 2016
• Bertrand Tombal, Brussels, Belgium*
The place of modern imaging in the management of
advanced prostate cancer
ICACT Congress, Centre de conférence,
Étoile Saint-Honoré, 21-23-25 rue Balzac - 75008 Paris
10th SURGICAL ONCOLOGY SEMINAR
9:00 – 12:30: Current
• David Khayat, Paris, France
New learnings in the management of advanced prostate
cancer
Carcinomatosis
Chaired by: Marc POCARD, Philippe LASSER (Paris)
• Clarisse EVENO (Lariboisière, Paris) : Cytoreduction surgery
and intraperitoneal chemotherapy for peritoneal metastasis,
what you can promise to your patients affected by a colon cancer
• Laurent VILLENEUVE (Lyon) : The RENAPE network in France,
for whom, what missions, what future?
• Jean-Marc GORNET (Saint-Louis, Paris) : What the medical
oncologist and multidisciplinary consultation meeting had to
know about peritoneal metastases to adress selected patients
for a curative treatment and then follow.
• Olivier GLEHEN (Lyon) : What the general surgeon should be
aware of peritoneal metastases not decrease the chances of
potentially eligible patients to curative treatment.
• Jean-Marc CLASSE (Nantes) : Role of surgery in case of
recurrence of ovarian origin carcinomatosis.
• Réa LO DICO (Lariboisière, Paris) : What place of surgery in
cases of carcinomatosis of gastric origin, NIPS, HIPEC, PIPAC?
• Cyril TOUBOUL (Créteil) : Understanding the peritoneum
as a microenvironment allows us for changing management
strategies carcinomatosis, eg ovarian carcinomatosis.
• Diane GOÉRÉ (Gustave Roussy, Villejuif) : HIPEC can heal very
extensive carcinomatosis - such as peritoneal peseudomyxoma.
• Nicolas Mottet, Saint-Etienne, France*
New hopes in high-risk localized prostate cancer
• Hendrik van Poppel, Belgium, France
Individualized approach to recurrent prostate cancer
after curative treatment
6 Wednesday 3rd February
n
ORION
9:00-12:30
Sarcoma & Melanoma
Chaired by A. Eggermont* & A. Le Cesne
• Axel LE CESNE – Villejuif, France*
The challenges if targeted treatment in sarcoma
• Axel LE CESNE – Villejuif, France*
What’s new in GIST?
12:30 -13:00: Surgical
• Robert BENJAMIN – Houston, USA*
Sarcoma: an overview
Oncology Awards 2015
Chaired by President David KHAYAT Fondation AVEC,
President Henri JUDET French Academy of Surgery
• Isabelle RAY-COQUARD – Lyon, France*
Conformity to the Guidelines, Epidemiology, Geography
and Managed Care Pathways are able to explain survival
more than biology for sarcoma patients?
“Surgical Oncology Award” 2015 to: X
“Junior Surgical Oncology Award to : X
13:00 -14:00 : Lunch break
• Alexander EGGERMONT – Villejuif, France *
Immuno check point in Melanoma
14:00 - 16:30: Soft
tissue and axial sarcomas
Chaired by: Sylvie BONVALOT (Curie, Paris), François GOUIN (Nantes)
• Jean-Michel COINDRE (Bordeaux) : Networking in sarcomas
• Gilles MISSENARD (Paris) : Pelvic chordomas: technic and
collaborations
• Bernard MEUNIER (Rennes) : Which treatment for what GIST?
• Pierre MEEUS (Lyon) : Pitfalls and treatment of retroperitoneal
sarcomas
• Nathalie CASSOUX (Curie, Paris) : Optimization of
retinoblastoma’s treatment
12:30 Adjourn
n
Management in Peritoneal
ORION
15:00-15:30
24th CLAUDE JACQUILLAT AWARD
CEREMONY FOR CLINICAL CANCER
RESEARCH. Eric VAN CUTSEM, MD PhD
• Estelle LECOINTE (Sarcoma Patient Euronet) : Patients
association acting in research, teaching programms and care
networks
3rd SAVCHUK AWARD
IN ONCOLOGY CEREMONY*
The Seminar is dedicated to all Surgeons interested in Oncology: the ICACT Congress
is free of charge for all participants registered by mail [email protected] through the French Academy of Surgery
Sandra SWAIN (Washington, USA)
4
Scientific Symposium on Preliminary Program
6 Thursday 4th February
6 Wednesday 3rd February
n
ORION
n
15:30-17:30
Presidential Session
Breast Cancer (3)
Chaired by G.N. Hortobagyi & D. Khayat
Chaired by G.H. Hortobagyi & P. Goodwin
• Eric VAN CUTSEM – Leuven, Belgium
Personalized treatment in colorectal cancer
• Pamela GOODWIN – Toronto, Canada
Breast Cancer Survivorship
• Sandra M. SWAIN – Washington, USA
Are we ready to individualize chemotherapy by breast
cancer subtype?
• George CHAHINE – Beirut, Lebanon
Advances in Her2/neu+ Breast Cancer patients
• Gabriel N. HORTOBAGYI – Houston, USA
New Directions in Hormone Receptor-Positive Breast
Cancers
• Frances SHEPHERD – Toronto, Canada
Second-line treatment for non-small cell lung cancer: is
there now a new standard of care?
• Kiyohiko HATAKE – Tokyo, Japan
Monoclonal antibody therapy in myeloma: is it better
than rituximab in lymphoma?
• Edith PEREZ – Jacksonville, USA
New trial in Breast cancer
n
VEGA
9:00-12:30
CASSIOPEE
n
VEGA
14:00-16:00
10:00-12:00
Poster Session
Round Table
Chaired by A. Herrera & M. Lichinitser
n
Optimization of new drug global
clinical development: the
contribution of Russia
AUSTRAL
9:00-12:00
Clinical symposium of Hematology
With the Institutionnal Support of Amgen
Opening remarks: Dr Alain HERRERA
• 9h-9h45 : Les nouveautés des Leucémies aigues :
Pr Nicolas Boissel –Paris
Discussion : 9h45-10h
The Russian contribution to global pivotal phase 3 trials
since one decade:
• The Russian point of view : Pr Lev DEMIDOV
• The US – EU point of view : Dr Jean-Pierre BIZZARI
• 10h00- 10h45 : Quoi de neuf dans le traitement du
Myélome Multiple ? Pr Mohamad Mohty – Paris
Discussion : 10h45-11h00
• 11h00-11h45 Actualités Lymphomes:
Pr Gandhi DAMAJ – Caen
Discussion : 11h45-12h00
• Overview of clinical research activities in Russia: organization, co-operative groups, regulatory aspects, main
fields / indications of interest / expertise.
Pr Vera GORBOUNOVA
• The Russian involvement in early clinical development
and translational research. Pr Sergey ORLOF
The expectations:
• From Russian investigators : Pr Lev DEMIDOV
• From US- EU investigators : Pr David KHAYAT
• From the industry : Dr Jean-Pierre BIZZARI
• Now how can we work together to do better and more
efficiently in bringing new innovative treatments to all
patients all around the world:
ALL Next steps and concluding remarks. Pr David KHAYAT
*Not yet confirmed
5
Scientific Symposium on Preliminary Program
6 Thursday 4th February
n
France
• Pr François GOLDWASSER
• Pr David KHAYAT
• Dr Alain TOLEDANO
• Pr Jean-Jacques ZAMBROWSKI
Mali
• Pr Sine BAYO
• Dr Madani LY
Maroc
• Dr Faouzi HABIB
• Pr Redouane SAMLALI
Sénégal
• Pr Serigne Magueye GUEYE
• Pr Diop
• Dr Doudou Diouf
Tunisie
• Dr Narjess Chaari
• Dr Adel Kallel
Autorités de santé (TBC)
BOREAL
9:00-12:30
Forum AFRICA
L’accès à l’Innovation en Cancérologie en
Afrique
SYMPOSIUM AFAC Février 2016 - DIFFUSION CAPITALES
8 PAYS AFRICAINS EN DIRECT
• La cancérologie en Afrique subsaharienne d’hier à
aujourd’hui : quelle place pour les innovations?
• Enjeux éthiques : responsabilité des soignants et des
décideurs dans l’accès à l’Innovation
• Enjeux économiques : quels modèles de décision ?
• Innovations technologiques : bénéfices attendus,
des cas pratiques, leurs coûts ciblées : accès limité en
Afrique ? Point de vue des firmes pharmaceutiques ?
12:30-14:00 Adjourn
• Financements des projets médicaux par des fonds
d’investissement : Pr Hatem El Gabaly (ancien ministre de
la santé d’Egypte)
n
CASSIOPÉE
9:00 - 12:30
Gynecologic Cancers
• Synthèse : quelle politique de santé pour l’accès aux
innovations en cancérologie en Afrique subsaharienne ?
Dr Raymonde Goudou Coffie (Ministre de la santé de Côte
d’Ivoire)
Chaired by I. Ray-Coquard
• Roman ROUZIER – Paris, France
Pregnancy and cancer
• Peter HARPER – London, UK
Anti angiogenics & parp inhibitors in ovarian cancer
relapse
• Isabelle RAY-COQUARD – Lyon, France
Uterine sarcoma …a specific management?
• Christophe POMEL – Clermont-Ferrand, France
1st line surgery…for ovarian cancer (front line versus neo
interval surgery)
Discussion avec Madame Yamina Benguigui, Ex-Ministre
de la Francophonie, pour soutiens et parrainages
gouvernementaux, et représentativité tutelles et
Monsieur Jean Louis Borloo, Président, Fondation
Energie pour l’Afrique
Algérie (TBC)
Bénin
• Pr Edgard AIDJI
• Pr Fabien HOUNGBE
• Pr Tiburce Martial ZANNOU
Burkina Faso
• Dr Aboubacar BAMBARA
• Dr Augustin BAMBARA
Cameroun
• Pr Paul NDOM
• Pr Albert MOUELE SONE
• Dr Dina BELL ESTHER
• Dr Etienne ATENGUENA
Congo-Brazzaville
• Pr Charles GOMBE MBALAWA
• Pr Jean-Bernard NKOUA MBON
• Pr Judith NSONDE MALANDA
• Dr Solomana Diane
• Dr Armand Thoussa
Côte d’Ivoire
• Pr Innocent ADOUBI
• Pr Judith DIDI-KOUKO COULIBALY
Egypte
• Pr Tamer El Nahas
• Pr Mahmoud El Meteini
• Dr Hussein Metwally
Gabon
• Pr Ernest BELEMBAOGO
n
ANDROMEDE
9:00-13:00
Gastrointestinal Tumors
Chaired by J. Tabernero & A. De Gramont
• Gérard MILANO – Nice, France
Targeting immune check-points in CRC
• Louis KAYITALIRE – New Jersey, USA
Pancreas: new treatments?
• Aimery DE GRAMONT – Paris, France
Improving clinical trials in colorectal cancer. Update of
the ARCAD program
• Josep TABERNERO – Barcelona, Spain
New Targets and agents in the treatment of gastric cancer
and colorectal cancer
• Yasushi TSUJI – Sapporo, Japan
Pyrimidine derivatives for the treatment of
gastrointestinal cancer: history, current status, and future
directions
• Josep TABERNERO – Barcelona, Spain
Overcoming drug resistance to ant-EGFR therapies in the
treatment of CRC
6
abstract
2016
27 International Congress on Anti-Cancer Treatment
th
Submission Guidelines
Abstracts
Submission
Deadline:
December 12th,
2015
- Abstracts have to be submitted electronically and in English
- Abstracts received after the deadline (December 12th, 2015) will not be considered
- Supply as much information as possible: the precise subject of study, methods used where appropriate,
summary of results obtained, conclusion
- As it is assumed that original work will be presented, no bibliographic references are necessary
- Selected abstracts will be published in the abstract book exactly as you submitted it. Therefore,
proofreading is essential, no modification will be possible after submission.
- Your abstract should not contain accents or any other invalid character, which would not be part of the
English alphabet.
- Your abstract’s text should not exceed 3,000 characters (excluding spaces)
- The main author (presenter) confirms that all authors are aware of and agree to the content of the
abstract and support of the data presented. By submitting his abstract, the author allows the 27th ICACT to
publish and distribute or sell his abstract as part of the Abstract Book, which may be distributed on paper.
- All selected abstracts will be published in the abstract book. Papers accepted for poster presentation will
be displayed during poster sessions.
- Acceptance or rejection of the paper by the Scientific Committee will be notified by email to the main
author (presenter) by December 13th, 2015
- Only persons whose registration is complete will be able to present their abstracts
- Posters will be awarded or encouraged: a special jury will select the three best posters and their authors
will receive the SOMPS Poster Award and a cheque of 500E each.
Registration (Allows to access all satellite meetings of ICACT)
REGISTRATION FEES (in Euros)
Regular Registration
Student*
From Jun. 15th 15 to Nov. 15th, 2015
450
225
From Nov. 16th 15 and on site
600
275
*Provided signed Certificate from the school is attached to the registration form
Way of Registration
Online Registration: secure online registration and payment by credit card via the website www.icact.com
Registration will be validated only with payment by credit card (Visa, Mastercard).
Registration Form sent by Fax or Mail:
you can download the registration form on the website and send it duly completed to the Organisation
Committee.
Registration will be validated only with payment attached or credit card information completed.
Cancellation Policy
Before November 2nd, 2015 : 50% cancellation fees
From November 3rd, 2015 : no refund
7
2016
27th International Congress on Anti-Cancer Treatment
Accommodation
Special prices have been negotiated to offer you the best value for the period Both
hotels are 3*** or 4**** and offer the best situation :
CONTACT US FOR ALL RESERVATION REQUEST
Booking only by Email : [email protected] or fax + 33 1 41 04 04 11 or post mail
Please fill the Registration Form
PAYMENT AND AGREEMENT
Deadline Registration for hotel room:
December 30th 2015
Full payment upon registration
• From October 30th to November 30th, 2015: 50% cancellation fees
• From December 1st to December 30th, 2015: 75% cancellation fees
• From December 31st, 2015 : rooms cancelled are non refundable
• Name changes are authorized till January 15th, 2016.
(Any change or cancellation must be validated by mail or fax)
PCO
Medical Department
[email protected]
Tel. : 00 33 (0)1 41 04 04 04 / Fax : 00 33 (0) 1 41 04 04 11
IME a tradmark of Equatour
19-21 rue Saint Denis - 92100 Boulogne-Billancourt
8
2016
27th International Congress on Anti-Cancer Treatment
MASTER GLOBAL MEETING SP • SPP • 210 x 297 mm • Visuel: Global Meeting 19 • Remise le : 25/10
MASTER GLOBAL MEETING SP • SPP • 210 x 297 mm • Visuel: Global Meeting 19 • Remise le : 25/10
OM • Relecture
OM • Relecture


Whether you are the organiser or the participant, the Global Meetings Program allows you to benefit
from the expertise of SkyTeam’s network covering over 1,000 destinations worldwide. Via the online
portal, not only can participants obtain discounted travel, but flights and connections are made more
convenient. Organisers can also take advantage of an online solution especially designed to meet their
needs, including a productivity reward program. Additionally, we provide you with a communications kit
and one point of contact to help manage your event. Visit our website www.skyteam.com/globalmeetings


Whether you are the organiser or the participant, the Global Meetings Program allows you to benefit
Whether you are the organiser or the participant, the Global Meetings Program allows you to benefit from the expertise of SkyTeam’s network covering over 1,000 destinations
from the expertise of SkyTeam’s network covering over 1,000 destinations worldwide. Via the online
worldwide. Via the online portal, not only can participants obtain discounted travel, but fl ights and connections are made more convenient. Organisers can also take advantage
portal, not only can participants obtain discounted travel, but flights and connections are made more
of an online solution
especially designed to meet their needs, including a productivity reward program. Additionally, we provide you with a communications kit and one point of
convenient.
canour
also
take advantage
of an online solution especially designed to meet their
contact to help manage
yourOrganisers
event. Visit
website
www.skyteam.com/globalmeetings
needs, including a productivity reward program. Additionally, we provide you with a communications kit
and one point of contact to help manage your event. Visit our website www.skyteam.com/globalmeetings

AIR FARE DISCOUNT - Event ID : 3030S

SkyTeam Global Meetings Agreement - This Agreement is entered into by and among member airlines of the SkyTeam Alliance and EQUATOUR
you are the
organiser
the offer
participant,
theairfares
Global for
Meetings
Program allows you to benefit

The airlines of SKYTEAM, Official Alliance Network
for 27th
ICACTor
2016,
attractive
participants.
from the expertise
SkyTeam’s
network covering
1,000with
destinations
Via the online
SKYTEAM comprises 19 leading international
airlinesofserving
1000 destinations
in 187 over
countries
over 15 000worldwide.
flights daily.
portal, not only can participants obtain discounted travel, but flights and connections are made more
convenient. Organisers can also take advantage of an online solution especially designed to meet their
GLOBAL MEETINGS PROGRAMME - TICKETS PURCHASING


needs, including a productivity reward program. Additionally, we provide you with a communications kit
The Discount Agreement will be
for
travel
between
January
28th
through
February
9th,
2016.
and one point of contact to help manage your event. Visit our website www.skyteam.com/globalmeetings
To benefit from these special offers, link up with http://globalmeetings.skyteam.com and quote the Identifier Code 3030S Tickets
purchased on the following Carriers are eligible for the SkyTeam Global Meetings programme:
Aeroflot, Aerolíneas Argentinas, Aeroméxico, Air Europa, Air France, Alitalia, China Airlines, China Eastern, China Southern, Czech
Airlines, Delta Air Lines, Kenya Airways, KLM Royal Dutch Airlines, Korean Air, Middle East Airlines, Saudia, TAROM, Vietnam Airlines
and Xiamen Air.
To book your travel now, visit www.skyteam.com/GlobalMeetings and enter your Event ID, 3030S
Through this site you can also access the schedules of all SkyTeam partners to plan your flights on the airline of your choice.
Comosol Group www.comosol.com , Paris - © Fotolia
EQUATOUR-IM 075 10 0360 RC Paris B 34390363900031
Whether
